A groundbreaking initiative is underway to explore ibogaine as a therapeutic treatment for opioid use disorder and other mental health conditions. High-profile public hearings revealed powerful testimonials, including one from a governor, emphasizing the urgent need for this treatment. Despite concerns about cardiac risks, key FDA scientists indicated that these issues may not disqualify ibogaine from clinical trials, igniting hope for its future development.
